Skip to document

Drug Care Mood Stabilizing Antiepileptic Agend Lamotrigine - Copy

Drug card
Course

Behavioral Health Nursing (NSG-322)

77 Documents
Students shared 77 documents in this course
Academic year: 2023/2024
Uploaded by:
Anonymous Student
This document has been uploaded by a student, just like you, who decided to remain anonymous.
Grand Canyon University

Comments

Please sign in or register to post comments.

Preview text

Drug Card – Mood-Stabilizing Antiepileptic Agent: Lamotrigine Action: Stabilizes neuronal membranes by inhibiting sodium transport Indications: Adjunct treatment of partial seizures in adults and children older than 2. Also used to delay mood episodes in bipolar clients Warnings: Pregnancy. If taking together with valproic acid or Depakote, a serious skin rash may be more likely. Do not take the drug if allergic to lamotrigine. Client should let provider know if history of kidney, liver, or heart disease Undesirable Effects: Ataxia, dizziness, drowsiness, blurred vision, headache, N/V, photosensitivity, rash. Stevens-Johnson syndrome, fever, sore throat, swollen glands, behavior changes, mood changes (depression, anxiety, agitation). Suicidal ideation Other Specific Information: Concurrent use with carbamazepine may result in decreased levels of lamotrigine and increased levels of an active metabolite of carbamazepine. Levels are decreased by concurrent use of phenobarbital, phenytoin, or primidone. Concurrent use with valproic acid results in a twofold increase in levels, increased incidence of rash, and decrease in valproic acid level. Oral contraceptives may decrease serum levels. Interventions: Monitor labs for renal function; monitor of plasma levels of Lamictal (proposed therapeutic range if 1-5 mcg/mL. Do not miss scheduled appointments with provider of care. Assess for skin rash, and d/c at first sign of rash (may be life-threatening). Stevens-Johnson syndrome or toxic epidermal necrolysis may develop. Rashh usually occurs during initial 2-8 weeks and is more frequent when taking multiple antiepileptic drugs, esp valproic acid. Clients < 16 at higher risk. Assess/monitor for hypersensitivity. Assess seizures. Assess mood, ideation and behaviors frequently. Initial suicide precautions as indicated PO may be administered with or without food. D/C gradually. Can swallow whole, chewed, or dispersed in water or juice. If chewed, follow with fluids. Only use whole tablets. Educations: May impair vision or ability to react in situations/reaction time. Check with provider or pharmacy about multiple drug-drug interactions r/t this medication. Do not d/c abruptly. Notify provider of rash or other adverse reactions. Initiate safety precautions due to drowsiness, dizziness, and possible blurred vision. Use sunscreen. Report changes in mood or suicidal thoughts. Evaluation: Decrease in frequency or cessation of seizures. Decrease in mood swings in bipolar d/o. Drug: lamotrigine (Lamictal)

Was this document helpful?

Drug Care Mood Stabilizing Antiepileptic Agend Lamotrigine - Copy

Course: Behavioral Health Nursing (NSG-322)

77 Documents
Students shared 77 documents in this course
Was this document helpful?
Drug Card – Mood-Stabilizing Antiepileptic Agent: Lamotrigine
Action: Stabilizes neuronal membranes by inhibiting sodium transport
Indications: Adjunct treatment of partial seizures in adults and children older than 2. Also used to delay
mood episodes in bipolar clients
Warnings: Pregnancy. If taking together with valproic acid or Depakote, a serious skin rash may be more
likely. Do not take the drug if allergic to lamotrigine. Client should let provider know if history of kidney,
liver, or heart disease
Undesirable Effects: Ataxia, dizziness, drowsiness, blurred vision, headache, N/V, photosensitivity, rash.
Stevens-Johnson syndrome, fever, sore throat, swollen glands, behavior changes, mood changes
(depression, anxiety, agitation). Suicidal ideation
Other Specific Information: Concurrent use with carbamazepine may result in decreased levels of
lamotrigine and increased levels of an active metabolite of carbamazepine. Levels are decreased by
concurrent use of phenobarbital, phenytoin, or primidone. Concurrent use with valproic acid results in a
twofold increase in levels, increased incidence of rash, and decrease in valproic acid level. Oral
contraceptives may decrease serum levels.
Interventions: Monitor labs for renal function; monitor of plasma levels of Lamictal (proposed
therapeutic range if 1-5 mcg/mL. Do not miss scheduled appointments with provider of care. Assess for
skin rash, and d/c at first sign of rash (may be life-threatening). Stevens-Johnson syndrome or toxic
epidermal necrolysis may develop. Rashh usually occurs during initial 2-8 weeks and is more frequent
when taking multiple antiepileptic drugs, esp valproic acid. Clients < 16 at higher risk. Assess/monitor
for hypersensitivity. Assess seizures. Assess mood, ideation and behaviors frequently. Initial suicide
precautions as indicated PO may be administered with or without food. D/C gradually. Can swallow
whole, chewed, or dispersed in water or juice. If chewed, follow with fluids. Only use whole tablets.
Educations: May impair vision or ability to react in situations/reaction time. Check with provider or
pharmacy about multiple drug-drug interactions r/t this medication. Do not d/c abruptly. Notify
provider of rash or other adverse reactions. Initiate safety precautions due to drowsiness, dizziness, and
possible blurred vision. Use sunscreen. Report changes in mood or suicidal thoughts.
Evaluation: Decrease in frequency or cessation of seizures. Decrease in mood swings in bipolar d/o.
Drug: lamotrigine (Lamictal)